Objective: dornase alfa (rhdnase) reduces the viscosity of purulent sputum in the lungs. the use in patients with cystic fibrosis (cf) is proven. however, the evidence of its applicability to other conditions is limited. this study aims to present the

HIGHLIGHTS

• who: Palavras-chave Desoxirribonuclease I and colleagues from the Centro Hospitalar Universitário do Porto, Porto, Portugal have published the article: Objective: Dornase alfa (rhDNase) reduces the viscosity of purulent sputum in the lungs. The use in patients with cystic fibrosis (CF) is proven. However, the evidence of its applicability to other conditions is limited. This study aims to present the, in the Journal: (JOURNAL) of May/29,/2020
• what: The aim of this study was to describe two cases from the authors' experience with the daily treatment with dornase alfa in PICU, specifically in . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.